Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT02511158
Recruiting Observational

French Prospective Anterior Cruciate Ligament Reconstruction Cohort Study (FAST)

NCT02511158 · tracked via the Priya Life Science France tracker
Sponsor
Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport
Phase
Observational
Started
2012-09
Last updated
2020-07-27

Condition(s) studied

Rupture of Anterior Cruciate LigamentOsteoarthritis

Investigational drug(s) / intervention(s)

Ligament of the knee reconstruction

Ligament of the knee reconstruction: Reconstruction of ligaments of the knee by autografts

Study summary

In this study we will examine patients who have undergone anterior cruciate and/or posterior cruciate ligament and/or multi ligaments reconstruction to determine the rate of re-injury, contralateral tear and functional outcomes at least two years after surgery.

Eligibility

Sex
ALL
Min age
7 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * One ligament or multi-ligaments tear of the knee * Surgery reconstruction with any technique Exclusion Criteria: * Patient refusal

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre Médico-Chirurgical Paris V (CMCV) Paris France Recruiting

More Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport trials in France

Proximal Hamstring Avulsion Surgery Cohort Study Recruiting

Other trials for the same condition

14022 ATTUNE Cementless RP Clinical Performance Evaluation Active, not recruiting
Zimmer POLAR Persona - TKA (EMEA Study) Active, not recruiting
G7 BiSpherical Acetabular Shell PMCF Study Active, not recruiting
Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis Recruiting
Persona Partial Knee Clinical Outcomes Study Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02511158 on ClinicalTrials.gov ↗ ← All trials in France